Clinical Trial Update: A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032) [Phase 3]

View source ↗

Summary

Phase 3 long-term safety and tolerability study of ezetimibe plus atorvastatin in patients with coronary heart disease, multiple risk factors, or hypercholester…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Hypercholesterolemia

Drugs mentioned

• ezetimibe plus atorvastatin

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED